Header Logo
Newsletter Podcast
Log In
← Back to all posts

Real Results with PRP, Staff Scripts That Work, and Events You’ll Love

May 06, 2025
Connect

Highlights

  • Today’s Research Article: PRP wins the long game — outperforms kinesiotaping for chronic heel pain with lasting relief and tissue regeneration.
  • Questions from the Field: Can you combine PRP and protein concentrate for osteoarthritis? Absolutely — and here’s why it works.
  • Let’s Get Down to Business: Your front desk is your secret salesforce — train them to sell PRP with empathy, not just prices.
  • Come Join Us: Get hands-on with regenerative medicine — meet us live at top events this May and July.

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

Regenerative efficacy of therapeutic quality platelet‐rich plasma injections versus phonophoresis with kinesiotaping for the treatment of chronic plantar fasciitis: A prospective randomized pilot study

Nitesh Gonnade, Archana Bajpayee, Abhay Elhence, Vaibhav Lokhande, Neeraj Mehta, Manish Mishra, Arunpreet Kaur

Read the full article here.

Summary:

This prospective randomized pilot study compared the long-term regenerative efficacy of autologous platelet-rich plasma (PRP) injections versus phonophoresis with kinesiotaping (KT) in patients with chronic plantar fasciitis unresponsive to conservative treatments. Out of 64 enrolled patients, 54 completed the 24-week follow-up. While KT provided better early pain relief at 2 weeks, PRP showed significantly greater improvements in pain (Numerical Rating Scale), foot function (Foot Function Index), and plantar fascia thickness at 12 and 24 weeks. The study used two ultrasound-guided PRP injections spaced two weeks apart, with a standardized preparation method ensuring high platelet concentration and minimal contamination.

The results support that PRP not only reduces symptoms but also promotes tissue regeneration in plantar fasciitis. Unlike KT, whose benefits were short-lived, PRP demonstrated sustained pain relief and structural improvement over six months, with no reported adverse effects. The study suggests that therapeutic-quality PRP injections can be a viable, cost-effective, and safer long-term option for managing chronic plantar fasciitis, especially in patients who have not responded to traditional therapies.

Doctor-to-Patient Talking Points on Why to Choose PRP (Based on the Study):

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
Lasting Relief, Better Outcomes—Plus What PRP Docs Are Doing Differently
Highlights Today’s Research Article: Your go-to treatment just got outperformed—see why PRP is leading in joint relief. Questions from the Field: Even if they’re under 65, it’s better to have the ABN signed—every time. Let’s Get Down to Business: Educate, personalize, and document—keys to building a thriving PRP practice. Come Join Us: Train smarter, connect deeper—your next breakthrou...
PRP Wins Big, Raise Your Rates, Master Your Marketing
Highlights Today’s Research Article: PRP delivers twice the healing at six months compared to steroids — and helps patients avoid surgery. Questions from the Field: When your results are better, your price should be too — charge for the quality and outcomes you deliver. Let’s Get Down to Business: If patients can’t find you online, they’ll never book — make digital marketing your best cl...
The Science, Strategy, and Events You Can’t Miss in Regenerative Medicine
Highlights Today’s Research Article: PRP Outperforms Physical Therapy in Tennis Elbow—With Healing You Can See on MRI. Questions from the Field: Bone Marrow vs. Adipose for Knees? Use the Right Tool for the Right Target. Let’s Get Down to Business: Stop Selling PRP Like a Backup Plan—Position It as the Smart, First-Line Solution. Come Join Us: Sharpen Your Skills and Expand Your Networ...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.